The Sleep Disorder Center Of Midatlanic is categorized under Medical Research in Fairfax, VA and active since 2004.
The Sleep Disorder Center Of Midatlanic was established in 2004, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact James Perlstrom at the company’s single location by writing to 10875 Main St # 212, Fairfax, Virginia VA 22030 or by phoning (412) 697-0999. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | The Sleep Disorder Center Of Midatlanic |
Contact Person: | James Perlstrom |
Address: | 10875 Main St # 212, Fairfax, Virginia 22030 |
Phone Number: | (412) 697-0999 |
Annual Revenue (USD): | $50.000 to $99.999 |
Founded: | 2004 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Medical Research |
SIC Code: | 8733 |
NAICS Code: | 541720 |
Share This Business: |
The Sleep Disorder Center Of Midatlanic was started in 2004 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact James Perlstrom for inquiries that concern The Sleep Disorder Center Of Midatlanic by calling the company number (412) 697-0999, as your correspondence is most welcome. Additionally, the physical location of the single location of The Sleep Disorder Center Of Midatlanic can be found at the coordinates 38.851134,-77.320611 as well as the street address 10875 Main St # 212 in Fairfax, Virginia 22030.
For its online presence, you may visit The Sleep Disorder Center Of Midatlanic’s website at and engage with its social media outlets through on Twitter and on Facebook.